We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Owner of the Marlboro brand in the US seeks to double revenues from smokeless products
Jacek Olczak says he is steering the tobacco group away from cigarettes towards ‘healthy solutions’
Company signals ‘no hope’ of a deal because of Kremlin terms on foreign companies’ asset sales
Activist hedge fund stands to make about $150mn in profit from deal
Hedge fund now has power to decide outcome of Philip Morris International’s $16bn offer for smokeless tobacco specialist
Cigarette maker bows to pressure from activist funds that have built stakes in smokeless tobacco specialist
Segment carries lower regulatory risk than traditional cigarettes
Even if its $16bn investment in Swedish Match disappoints, annual cigarette sales of 600bn provide decent insurance
Acquisition takes company further into market for tobacco-free alternatives to cigarettes
European group’s success with chewing tobacco and pouches make for a tidy addition
Marlboro seller close to acquisition of maker of snus tobacco pouches in further shift away from cigarettes
Companies turn to share buybacks as investors ditch stocks over ESG concerns
Chief executive Jacek Olczak tells FT that chapter involving fellow tobacco group is ‘closed’
Japanese pharma company says Medicago’s product will be cheaper to make and easier to transport
Cigarette maker secures majority of shares in UK-based medical device manufacturer
Shareholders in UK inhaler maker will have final say in a takeover battle that has divided opinion
We must allow companies to reinvent themselves and address the problems they helped create
Short-term rental provider reports strong revenue growth, but warns on spread of Covid variants
Inhaler maker draws criticism from health charity for ‘absurd’ deal
UK inhaler group has bungled handling competing interests from cigarette-maker Philip Morris and Carlyle
UK regulator to oversee five days of bidding for Vectura by cigarette producer and private equity firm
Tobacco group lifts bid above £1bn in battle with Carlyle as private equity targets British businesses
Brand ‘will disappear’ from UK shelves under diversification strategy, says chief executive
Philip Morris International’s deal to buy inhaler company Vectura creates confusion on both sides
Many groups are diversifying but the traditional smoking business is still the big money spinner
International Edition
